A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Beijing Biotech
Incyte Corporation
Servier
Sumitomo Pharma America, Inc.
Curis, Inc.
Dana-Farber Cancer Institute
Auron Therapeutics, Inc.
Senti Biosciences
NextCure, Inc.
Prelude Therapeutics